Predictive Model for Mortality in Older People With Critical Illness
VITA
Development of a Predictive Model for Mortality in Patients Aged 75 or Older With Critical Illness
1 other identifier
observational
450
1 country
15
Brief Summary
The present study aims to develop a predictive model to identify elderly patients with the highest likelihood of mortality upon admission to an intensive care unit.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2025
15 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 5, 2024
CompletedFirst Posted
Study publicly available on registry
December 11, 2024
CompletedStudy Start
First participant enrolled
March 20, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2026
December 2, 2025
December 1, 2025
1.7 years
December 5, 2024
December 1, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
mortality
mortality on day 90 from admission to Intensive Care Unit
Day 90
Interventions
Results of laboratory biomarker analysis will be analyzed as predictors for mortality
Eligibility Criteria
Patients admitted to a Intensive Care Unit
You may qualify if:
- Men and women aged 75 or older.
- Admission to an ICU from the Emergency Department.
- Availability of or possibility to contact a participant's informant.
- Informed consent for participation in the study, either by the participant or a valid legal representative.
You may not qualify if:
- Patients transferred to the Emergency Department from a hospital ward.
- Patients who die within the first 24 hours of ICU admission.
- Patients admitted to Step-Down Units.
- Patients requiring ICU admission for any of the following reasons:
- Orotracheal intubation or advanced cardiopulmonary resuscitation performed prior to arrival at the Emergency Department.
- AV block awaiting pacemaker implantation. Activation of the STEMI or Stroke care pathway. Post-cardiac catheterization for acute coronary syndrome.
- Participation in another clinical study involving an intervention, procedure, or visit schedule that is incompatible with the present study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (15)
Hospital German Trias i Pujol
Badalona, Barcelona, 08916, Spain
Consorci Sanitari Alt Penedès-Garraf
Sant Pere de Ribes, Barcelona, 08810, Spain
Hospital Clinic
Barcelona, Spain
Hospital de Barcelona
Barcelona, Spain
Hospital de la Santa Creu i Sant Pau
Barcelona, Spain
Hospital de Mataró
Barcelona, Spain
Hospital de Terrassa
Barcelona, Spain
Hospital del Mar
Barcelona, Spain
Hospital Dexeus Barcelona
Barcelona, Spain
Hospital General de Catalunya
Barcelona, Spain
Hospital General de Granollers
Barcelona, Spain
Hospital Sagrat Cor
Barcelona, Spain
Clinica Girona
Girona, Spain
Hospital Santa Caterina
Girona, Spain
Hospital Universitari Dr. Josep Trueta
Girona, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 5, 2024
First Posted
December 11, 2024
Study Start
March 20, 2025
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
December 1, 2026
Last Updated
December 2, 2025
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF
- Time Frame
- After publication of main results of the study.
- Access Criteria
- IPD will be shared only for scientific research purposes and following the Spanish and European Union normative law about data protection. The requirements will be directed to the IP of the study. The IP will evaluate the request to verify and evaluate the data that is requested and the purposes for which it is requested. Next, the IP will transfer the request to the promotor center the study for the final decision.
IPD (without personal identification data) could be shared by requirement from other researchers after the end of the study, and only for research purposes and previous approval of promotor center of the study (CSAPG). Anyway, Spanish and European Union legal policy about data protection will strictly be followed (IPD will not be transferred outside European Union).